» Articles » PMID: 11558841

Effect of Ethnicity and Hypertension on Atrial Conduction: Evaluation with High-resolution P-wave Signal Averaging

Overview
Journal Clin Cardiol
Date 2001 Sep 18
PMID 11558841
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Measurements by P-wave signal-averaged electrocardiogram (P-SAECG) of P-wave duration and P-wave voltage integral are higher in patients with atrial fibrillation (AF) than in those with sinus rhythm. Hypertension is perhaps the most common cardiovascular antecedent cause of AF, and particularly a disproportionate cause of morbidity and mortality among blacks. The purpose of this study was to examine the effect of hypertension and ethnicity on P-SAECG parameters in patients without AF.

Hypothesis: It was hypothesized that P-SAECG parameters can identify hypertensives, and are disproportionately higher in hypertensive blacks.

Methods: In all, 234 normotensives and 84 hypertensives underwent P-SAECG analysis. In an ancillary study group of 34 hypertensive black men, the relationship between severity of hypertension and measured parameters of P-SAECG was evaluated.

Results: Mean filtered P-wave duration and total P-wave voltage integral for normotensives of both ethnic groups were similar. Hypertensive blacks had greater increase in P-wave duration (138 +/- 16 vs. 132 +/- 12ms;p < 0.01, N42:42) and total P-wave voltage integral (922 +/- 285 vs. 764 +/- 198 microV-ms; p < 0.001) than white hypertensives. Filtered P-wave duration and total P-wave voltage integral increased with severity of hypertension.

Conclusions: Patients at very early stages of hypertension have demonstrable evidence of prolonged atrial conduction by P-SAECG and, thus, cardiac electrical remodeling. P-wave duration and total P-wave voltage integral increase with severity of hypertension. Hypertensive blacks manifest a greater increase in P-SAECG parameters than whites. This may portend an increased cardiovascular risk for black patients with hypertension.

Citing Articles

Electrocardiogram (ECG) for the Prediction of Incident Atrial Fibrillation: An Overview.

Aizawa Y, Watanabe H, Okumura K J Atr Fibrillation. 2018; 10(4):1724.

PMID: 29487684 PMC: 5821635. DOI: 10.4022/jafib.1724.


Differential impact of race and risk factors on incidence of atrial fibrillation.

Gbadebo T, Okafor H, Darbar D Am Heart J. 2011; 162(1):31-7.

PMID: 21742087 PMC: 3137277. DOI: 10.1016/j.ahj.2011.03.030.


Nebivolol and quinapril reduce p-wave duration and dispersion in hypertensive patients.

Korkmaz H, Onalan O, Akbulut M, Ozbay Y Indian Pacing Electrophysiol J. 2009; 9(3):158-66.

PMID: 19471593 PMC: 2683636.


Signal-averaged P wave duration and the dimensions of the atria.

Dixen U, Joens C, Rasmussen B, Parner J, Jensen G Ann Noninvasive Electrocardiol. 2004; 9(4):309-15.

PMID: 15485507 PMC: 6932350. DOI: 10.1111/j.1542-474X.2004.94533.x.

References
1.
Mosterd A, DAgostino R, Silbershatz H, Sytkowski P, Kannel W, Grobbee D . Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med. 1999; 340(16):1221-7. DOI: 10.1056/NEJM199904223401601. View

2.
Chapman J, Mayet J, Chang C, Foale R, Thom S, Poulter N . Ethnic differences in the identification of left ventricular hypertrophy in the hypertensive patient. Am J Hypertens. 1999; 12(5):437-42. DOI: 10.1016/s0895-7061(99)00027-8. View

3.
Kubara I, Ikeda H, Hiraki T, Yoshida T, Ohga M, Imaizumi T . Dispersion of filtered P wave duration by P wave signal-averaged ECG mapping system: its usefulness for determining efficacy of disopyramide on paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 1999; 10(5):670-9. DOI: 10.1111/j.1540-8167.1999.tb00244.x. View

4.
Aytemir K, Aksoyek S, Yildirir A, Ozer N, Oto A . Prediction of atrial fibrillation recurrence after cardioversion by P wave signal-averaged electrocardiography. Int J Cardiol. 1999; 70(1):15-21. DOI: 10.1016/s0167-5273(99)00038-8. View

5.
. Return of elevated blood pressure after withdrawal of antihypertensive drugs. Circulation. 1975; 51(6):1107-13. DOI: 10.1161/01.cir.51.6.1107. View